Related Experiment Video
Updated: May 11, 2026
06:48
An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 18, 2013
STAT5A/B gene locus undergoes amplification during human prostate cancer progression
Bassem R Haddad1, Lei Gu, Tuomas Mirtti
1Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA.
The American Journal of Pathology
|May 11, 2013
Summary
Gene amplification of STAT5A/B drives prostate cancer progression. This finding reveals a new mechanism for advanced prostate cancer and identifies STAT5A/B as a potential therapeutic target for aggressive disease.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Prostate cancer (PCa) progression to castrate-resistant and metastatic disease involves poorly understood molecular mechanisms.
- Previous work implicated transcription factor STAT5A/B in PCa cell invasion and progression, with elevated nuclear levels in high-grade and metastatic PCa.
- STAT5A/B is a potential therapeutic target for advanced prostate cancer, but the reasons for its increased levels in PCa were unclear.
Purpose of the Study:
- To investigate the mechanisms underlying increased STAT5A/B protein levels in prostate cancer.
- To determine if STAT5A/B gene amplification contributes to prostate cancer progression and aggressiveness.
Main Methods:
- Analysis of STAT5A/B gene locus in clinical prostate cancer specimens.
- Quantitative in situ hybridization to assess gene copy number and protein expression.
- In vitro and in vivo functional studies using PCa cell lines and xenograft models.
Main Results:
- Somatic STAT5A/B gene amplification was identified in a significant fraction of clinical PCa specimens.
- Gene amplification was more prevalent in high-grade PCas and castrate-resistant distant metastases.
- STAT5A/B gene amplification correlated with increased STAT5A/B protein expression and conferred a growth advantage in vitro and in vivo.
Conclusions:
- This study provides the first evidence of somatic STAT5A/B gene amplification in clinical prostate cancer.
- STAT5A/B gene amplification is a mechanism contributing to increased STAT5A/B levels and driving prostate cancer progression.
- STAT5A/B represents a promising therapeutic target for advanced and metastatic prostate cancer.
Related Concept Videos
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...